Why is the rectal route for NSAIDS favorable for preventing post-ERCP pancreatitis? Swaminathan G, Lin YC, Ni J, Khalid A, et al. Pancreatology 2025 Feb 4:S1424-3903(25)00032-8. doi: 10.1016/j.pan.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Swaminathan G, Lin YC, Ni J, Khalid A, et al. Why is the rectal route for NSAIDS favorable for preventing post-ERCP pancreatitis? Pancreatology 2025 Feb 4:S1424-3903(25)00032-8. doi: 10.1016/j.pan.2025.
PMID: 39922728